EquityStory.RS, LLC-Ad-hoc: PJSC Mosenergo / Key word(s): AGM/EGM The Annual General Meeting of Shareholders of PJSC 'Mosenergo' Will Be Held in Form of Absentee Voting on June 23 21-May-2021 / 15:58
Representative Image
12 ad hoc teachers, including 6 covid positive, removed from DU s Vivekananda College citing no workload ANI | Updated: May 17, 2021 16:07 IST
By Joymala Bagchi
New Delhi [India], May 17 (ANI): Amid the ongoing Covid-19 pandemic, 12 ad-hoc teachers from Delhi University s Vivekananda College, including six who are Covid-positive, have been removed from their post citing less workload .
As per the Delhi University Teachers Union s (DUTA) data, Vivekananda college has 42 permanent teachers and 69 ad hoc teachers out of which 12 have been removed.
Out of 12 thousand teachers, around 6 thousand have been appointed on an ad hoc basis in Delhi University. Ad hocs get their renewal every 4 months. The services of the 12 teachers were not renewed.
EQS-Adhoc: HBM Healthcare Investments AG: 15.05.2021
15.05.2021
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
in CHF
1 993
CYTD Calendar Year to Date (since 1.1.2021)
HBM Healthcare Investments AG
Fax +41 41 710 75 78
E-Mail: hbm@hbmhealthcare.com
Should you wish to unsubscribe from all HBM Healthcare Investments news, please unsubscribe here.
Disclaimer:
This message may contain confidential or privileged Information and is intended only for the use of the addressee named above. If you are not the intended recipient of this message, you are hereby notified that you must not use, copy, disclose or take any action based on this message or information herein. If you have received this message by error, please advise the sender immediately and delete this message. The publication is for information purposes only and does not constitute an offer to sell or a solicitation to buy or subscribe
EQS-Adhoc: Lonza Group AG: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)
Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)
06-May-2021 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Lonza will invest approximately CHF 850 million to build two new state-of-the-art mammalian facilities and respond to customer demand regarding capacity, life cycle management and speed to market
A new large-scale facility with the latest manufacturing technology in Visp (CH), will expand capacity by six 20,000L bioreactors to meet increasing market demand for biologics